Brief

With breakthrough efficacy in gold-standard preclinical models big pharma collaborations now valued over $1 billion, we are seeking an experienced Head of R&D to design the pathway to IND with the goal of moving multiple assets into the Clinic within the next year.

About The Company

High-tech, privately owned Biotech developing a new technology in immunotherapy that has already been shown to be 30 times more effective. The company has demonstrated breakthrough efficacy in gold-standard preclinical models of Multiple Sclerosis (MS) and Type-1 Diabetes (T1D), which serves as proof of concept for the potential utility of their therapy in a wide range of autoimmune diseases.

About The Role

Reporting to the CEO, this position will be responsible for building R&D team and moving multiple assets in Clinical Stages, ideally within the next year.

Will be doing little bit of everything in line with R&D efforts and will be responsible for designing the pathway to IND.

Must Have Requirements

Expertise in peptide-mediated immunotherapy

Expertise in Autoimmune disease

PhD in Immunology or Chemistry related fields

History of successfully leading and developing R&D teams

History of successful leading assets to IND

Industry

Biotech

Type

Privately owned

Employees

10

Funding

$250M + Big pharma collaborations valued over $1 billion